{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:41:06Z","timestamp":1793410866976,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.schres.2007.04.025","type":"journal-article","created":{"date-parts":[[2007,6,14]],"date-time":"2007-06-14T08:27:18Z","timestamp":1181809638000},"page":"29-36","source":"Crossref","is-referenced-by-count":227,"title":["Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use"],"prefix":"10.1016","volume":"94","author":[{"given":"F. Markus","family":"Leweke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Koethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit M.","family":"Nolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kranaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam A.","family":"Neatby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph W.","family":"Gerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Klosterk\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2007.04.025_bib1","series-title":"DSM-IV","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"8574","key":"10.1016\/j.schres.2007.04.025_bib2","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia. A longitudinal study of Swedish conscripts","volume":"2","author":"Andreasson","year":"1987","journal-title":"Lancet"},{"issue":"7374","key":"10.1016\/j.schres.2007.04.025_bib3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.schres.2007.04.025_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","article-title":"Causal association between cannabis and psychosis: examination of the evidence","volume":"184","author":"Arseneault","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"1-3","key":"10.1016\/j.schres.2007.04.025_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2005.12.017","article-title":"Prenatal exposure to a cannabinoid receptor agonist does not affect sensorimotor gating in rats","volume":"531","author":"Bortolato","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.schres.2007.04.025_bib6","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1046\/j.1471-4159.1999.0732447.x","article-title":"Chronic delta-9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain","volume":"73","author":"Breivogel","year":"1999","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.schres.2007.04.025_bib7","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/sj.npp.1300458","article-title":"A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic transmission","volume":"29","author":"Centonze","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2007.04.025_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-511X-2-5","article-title":"Endocannabinoid signalling in the blood of patients with schizophrenia","volume":"2","author":"De Marchi","year":"2003","journal-title":"Lipids, Health Dis."},{"issue":"1","key":"10.1016\/j.schres.2007.04.025_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use","volume":"103","author":"Dean","year":"2001","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.schres.2007.04.025_bib12","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1046\/j.1471-4159.2000.0741627.x","article-title":"Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats","volume":"74","author":"Di Marzo","year":"2000","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.schres.2007.04.025_bib8","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.schres.2007.04.025_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction","volume":"57","author":"D'Souza","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"23","key":"10.1016\/j.schres.2007.04.025_bib13","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1073\/pnas.0400997101","article-title":"Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172","volume":"101","author":"Fegley","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.schres.2007.04.025_bib14","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1460-9568.2003.02896.x","article-title":"Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias","volume":"18","author":"Ferrer","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2007.04.025_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0896-6273(03)00423-9","article-title":"The synaptic hypothesis of schizophrenia","volume":"39","author":"Frankle","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.schres.2007.04.025_bib16","series-title":"Behandlungs-leitlinie Schizophrenie","article-title":"S3 - Praxisleitlinien in Psychiatrie und Psychotherapie","author":"Gaebel","year":"2006"},{"issue":"4","key":"10.1016\/j.schres.2007.04.025_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","article-title":"Dopamine activation of endogenous cannabinoid signaling in dorsal striatum","volume":"2","author":"Giuffrida","year":"1999","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2007.04.025_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/abio.2000.4509","article-title":"Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry","volume":"280","author":"Giuffrida","year":"2000","journal-title":"Anal. Biochem."},{"issue":"11","key":"10.1016\/j.schres.2007.04.025_bib17","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.schres.2007.04.025_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study on the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"issue":"7481","key":"10.1016\/j.schres.2007.04.025_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.38267.664086.63","article-title":"Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people","volume":"330","author":"Henquet","year":"2005","journal-title":"Br. Med. J."},{"issue":"5","key":"10.1016\/j.schres.2007.04.025_bib22","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.schres.2007.04.025_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"1\u20133","key":"10.1016\/j.schres.2007.04.025_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.schres.2006.07.023","article-title":"Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness","volume":"88","author":"Koethe","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.04.025_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-007-0660-5","article-title":"Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression","author":"Koethe","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.schres.2007.04.025_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/schbul\/23.2.195","article-title":"Substance use disorder and the early course of illness in schizophrenia and affective psychosis","volume":"23","author":"Kovasznay","year":"1997","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2007.04.025_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(99)00067-0","article-title":"Increased dopamine transmission in schizophrenia: relationship to illness phases","volume":"46","author":"Laruelle","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.025_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1300.063","article-title":"Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment","volume":"1003","author":"Laruelle","year":"2003","journal-title":"Ann. N.Y. Acad Sci."},{"issue":"8","key":"10.1016\/j.schres.2007.04.025_bib29","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","article-title":"Elevated endogenous cannabinoids in schizophrenia","volume":"10","author":"Leweke","year":"1999","journal-title":"NeuroReport"},{"issue":"3","key":"10.1016\/j.schres.2007.04.025_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130050884","article-title":"Effects of synthetic \u03949-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man","volume":"142","author":"Leweke","year":"1999","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.schres.2007.04.025_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","article-title":"Cannabis abuse and the course of recent-onset schizophrenic disorders","volume":"51","author":"Linszen","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2007.04.025_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cne.903270406","article-title":"Localization of cannabinoid receptor mRNA in rat brain","volume":"327","author":"Matsuda","year":"1993","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.schres.2007.04.025_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/02791072.2003.10400013","article-title":"Measurement of adolescent drug use","volume":"35","author":"Morral","year":"2003","journal-title":"J. Psychoact. Drugs"},{"issue":"11","key":"10.1016\/j.schres.2007.04.025_bib34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev., Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2007.04.025_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0091-3057(03)00140-0","article-title":"Reduced binocular depth inversion in regular cannabis users","volume":"75","author":"Semple","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.schres.2007.04.025_bib36","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/sj.bjp.0705706","article-title":"Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex","volume":"141","author":"Steffens","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.schres.2007.04.025_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.mp.4001029","article-title":"CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia","volume":"7","author":"Ujike","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2007.04.025_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwf043","article-title":"Cannabis use and psychosis: a longitudinal population-based study","volume":"156","author":"van Os","year":"2002","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.schres.2007.04.025_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1176\/appi.ajp.161.3.501","article-title":"Cannabis use and age at onset of schizophrenia","volume":"161","author":"Veen","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2007.04.025_bib40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15288\/jsa.1996.57.273","article-title":"Contradictory subject response in longitudinal research","volume":"57","author":"Weinfurt","year":"1996","journal-title":"J. Stud. Alcohol"},{"issue":"7374","key":"10.1016\/j.schres.2007.04.025_bib41","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","article-title":"Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study","volume":"325","author":"Zammit","year":"2002","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.schres.2007.04.025_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407001909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407001909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T12:26:22Z","timestamp":1546777582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996407001909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":42,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0920996407001909"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2007.04.025","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}